Therapeutic application of regeneration-associated cells: a novel source of regenerative medicine, Stem Cell Research & Therapy

Chronic diseases with comorbidities or associated risk factors may impair the function of regenerative cells and the regenerative microenvironment. Following this consideration, the vasculogenic conditioning culture (VCC) method was developed to boost the regenerative microenvironment to achieve regeneration-associated cells (RACs), which contain vasculogenic endothelial progenitor cells (EPCs) and anti-inflammatory/anti-immunity cells. Preclinical and clinical studies demonstrate that RAC transplantation is a safe and convenient cell population for promoting ischemic tissue recovery based on its strong vasculogenicity and functionality. The outputs of the scientific reports reviewed in the present study shed light on the fact that RAC transplantation is efficient in curing various diseases. Here, we compactly highlight the universal features of RACs and the latest progress in their translation toward clinics.

Cell Therapy for Androgenetic Alopecia: Elixir or Trick?

What is regenerative medicine? A look into the future

Regenerative Medicine Market Size & Share Report, 2030

Interleukin-10 Deficiency Alters Endothelial Progenitor Cell

Clinical applications of stem cell-derived exosomes

Frontiers Urine-derived stem cells in neurological diseases

Cell potency - Wikipedia

MSCs in regenerative medicine: mesenchymal stem cells are CD73⁺, CD90⁺

Therapeutic application of regeneration-associated cells: a novel